Guided Therapeutics (GTHP) EPS (Weighted Average and Diluted) (2015 - 2025)
Guided Therapeutics' (GTHP) quarterly EPS (Weighted Average and Diluted) came in at -$0.01 in Q4 2025, up 50.0% year-on-year from -$0.01 in Q4 2024, and little changed quarter-over-quarter from -$0.01 in Q3 2025.
Guided Therapeutics (GTHP) EPS (Weighted Average and Diluted) (2015 - 2025) Analysis & Trends
Guided Therapeutics has disclosed EPS (Weighted Average and Diluted) across 11 years of filings, most recently posting -$0.01 for Q4 2025.
- EPS (Weighted Average and Diluted) for Q4 2025 came in at -$0.01, up 50.0% year-over-year; the trailing twelve-month figure through Dec 2025 was -$0.04 (up 20.0% YoY), and the FY2025 annual result was -$0.04, up 20.0% from the prior year.
- EPS (Weighted Average and Diluted) came in at -$0.01 for Q4 2025 at Guided Therapeutics, roughly flat from -$0.01 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of -$0.0 in Q3 2021 to a low of -$0.09 in Q2 2021.
- The 5-year median for EPS (Weighted Average and Diluted) is -$0.02 (2023), against an average of -$0.02.
- Across the five-year window, EPS (Weighted Average and Diluted) soared 84.21% in 2021 and sank 689.24% in 2022, its largest moves.
- Guided Therapeutics' EPS (Weighted Average and Diluted) stood at -$0.04 in 2021, then dropped by 0.0% to -$0.04 in 2022, then jumped by 77.07% to -$0.01 in 2023, then sank by 118.04% to -$0.02 in 2024, then surged by 50.0% to -$0.01 in 2025.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.01 (Q4 2025), -$0.01 (Q3 2025), and -$0.01 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 0.61 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 1.93 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 0.89 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 0.66 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 0.51 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 0.85 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 2.24 |
| 10 | Guided Therapeutics | - | - | 458,000.00 | -0.01 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.01 |
| Sep 30, 2025 | -0.01 |
| Jun 30, 2025 | -0.01 |
| Mar 31, 2025 | -0.01 |
| Dec 31, 2024 | -0.02 |
| Sep 30, 2024 | -0.01 |
| Jun 30, 2024 | -0.01 |
| Mar 31, 2024 | -0.01 |
| Dec 31, 2023 | -0.01 |
| Sep 30, 2023 | -0.01 |
| Jun 30, 2023 | -0.03 |
| Mar 31, 2023 | -0.02 |
| Dec 31, 2022 | -0.04 |
| Sep 30, 2022 | -0.03 |
| Jun 30, 2022 | -0.04 |
| Mar 31, 2022 | -0.05 |
| Dec 31, 2021 | -0.04 |
| Sep 30, 2021 | 0.00 |
| Jun 30, 2021 | -0.09 |
| Mar 31, 2021 | -0.04 |